Who are Candin, Intradermal Solution's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/candin-intradermal-solution.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-14 · How we verify

Candin, Intradermal Solution — Competitive Intelligence Brief

Candin, Intradermal Solution (Candin, Intradermal Solution) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Immunotherapeutic antigen preparation. Area: Immunology / Infectious Disease.

phase 3 Immunotherapeutic antigen preparation Candida albicans antigens Immunology / Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

Candin, Intradermal Solution (Candin, Intradermal Solution) — Nielsen BioSciences, Inc.. Candin is a candida albicans antigen preparation that stimulates delayed-type hypersensitivity and cell-mediated immune responses against candida infections.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Candin, Intradermal Solution TARGET	Candin, Intradermal Solution	Nielsen BioSciences, Inc.	phase 3	Immunotherapeutic antigen preparation	Candida albicans antigens

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Immunotherapeutic antigen preparation class)

Nielsen BioSciences, Inc. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Candin, Intradermal Solution — Competitive Intelligence Brief. https://druglandscape.com/ci/candin-intradermal-solution. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab